Edwards Lifesciences (EW) Other Gross PP&E Adjustments (2009 - 2026)

Edwards Lifesciences has reported Other Gross PP&E Adjustments for 14 years, with the latest figure at -$99.3 million in Q1 2026.

• For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 2.48% year-over-year to -$99.3 million; the trailing twelve-month figure through Mar 2026 stood at -$99.3 million (down 2.48% YoY), and the FY2025 full-year result was $789.5 million, up 1.43% from the prior year.
• Other Gross PP&E Adjustments for Q1 2026 stood at -$99.3 million, down from $789.5 million in the prior quarter.
• The five-year high for Other Gross PP&E Adjustments was $789.5 million in Q4 2025, with the low at -$104.4 million in Q3 2024.
• Average Other Gross PP&E Adjustments over 5 years is $53.4 million, with a median of -$90.9 million recorded in 2023.
• Year-over-year, Other Gross PP&E Adjustments jumped 800.54% in 2023 and retreated 14.85% in 2024.
• Tracing EW's Other Gross PP&E Adjustments over 5 years: stood at -$92.3 million in 2022, then jumped by 800.54% to $646.6 million in 2023, then grew by 20.38% to $778.4 million in 2024, then gained by 1.43% to $789.5 million in 2025, then plunged by 112.58% to -$99.3 million in 2026.
• The last three Other Gross PP&E Adjustments figures came in at -$99.3 million (Q1 2026), $789.5 million (Q4 2025), and -$96.5 million (Q3 2025), per Business Quant data.

Peer Comparison